PA-21-259, sbir, phase I, self-amplifying RNA replicon-based platform for generating multivalent influenza vaccine
Ended Formula Grant Awarded Last action
- Award ID
- R43IP001228
- Recipient
-
Carogen Corp UEI JNMNVKEUU2Y3
- Awarding agency
-
Office of Financial Resources
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $527,981
Award facts
- Assistance listing
- 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance
- Completion date
- Originally
- Funding agency
- Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
- Place of performance
- Farmington, CT, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$1 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $263,991 | |
| Original award | $263,991 |
Quick answers
Who received award R43IP001228?
R43IP001228 was awarded to Carogen Corp by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2023.
How much is award R43IP001228 worth?
$527,981 has been obligated on R43IP001228.
Which agency awarded R43IP001228?
Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43IP001228, with funding from Office of the Director (Centers for Disease Control and Prevention).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award